Rhythm Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. 

CEO
David P. Meeker
CEODavid P. Meeker
Employees
226
Employees226
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2008
Founded2008
Employees
226
Employees226

RYTM Key Statistics

Market cap
2.32B
Market cap2.32B
Price-Earnings ratio
-8.18
Price-Earnings ratio-8.18
Dividend yield
—
Dividend yield—
Average volume
626.14K
Average volume626.14K
High today
$39.45
High today$39.45
Low today
$37.25
Low today$37.25
Open price
$39.45
Open price$39.45
Volume
741.68K
Volume741.68K
52 Week high
$52.57
52 Week high$52.57
52 Week low
$15.50
52 Week low$15.50

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.